Welcome to the Amprion 2023 landing page! From here you can download through the links below or explore the rest of our website.
We are excited be exhibiting at MDS 2023
Booth #263
Poster# 253
Date: Monday, August 28, 2023
Time: 1:00pm-3:00pm CEST
Title: Widespread Synuclein Pathology in Hyposmics precedes dopamine transporter deficit in PARS.
Poster #33
Date: Monday, August 28, 2023
Time: 1:00pm– 3:00pm CEST
Title: A staged screening paradigm to identify people at rest of Parkinson’s disease in the Parkinson’s Progression Markers Initiative
Misfolded α-synuclein (αSyn) aggregates (αSyn-seeds) in cerebrospinal fluid (CSF) are biomarkers for synucleinopathies
“Mov Disord. 2023”
The purpose of this study was to determine the sensitivity and specificity of α-synuclein seed amplification
“Ann Neurol. 2022”
Biomarkers for α-synucleinopathies that reflect underlying pathology are sorely needed to improve the accuracy of early diagnosis and identify subtypes based on molecular factors and thus accelerate clinical trials.
“Movement Disorders, June 2023”
